[1] |
Rothnie KJ, Müllerová H, Smeeth L, et al. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care, 2018; 198, 464−71. doi: 10.1164/rccm.201710-2029OC |
[2] |
Müllerova H, Maselli DJ, Locantore N, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest, 2015; 147, 999−1007. doi: 10.1378/chest.14-0655 |
[3] |
Soriano JB, Lamprecht B, Ramírez AS, et al. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir Med, 2015; 3, 443−50. doi: 10.1016/S2213-2600(15)00157-5 |
[4] |
Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med, 2013; 1(1), 43−50. |
[5] |
Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care, 2003; 167, 544−9. doi: 10.1164/rccm.200206-583OC |
[6] |
Chuang ML, Huang SF, Su CH. Cardiovascular and respiratory dysfunction in chronic obstructive pulmonary disease complicated by impaired peripheral oxygenation. Int J Chron Obstruct Pulmon Dis, 2015; 10, 329−37. |
[7] |
Stickland MK, Neder JA, Guenette JA, et al. Using cardiopulmonary exercise testing to understand dyspnea and exercise intolerance in respiratory disease. Chest, 2022; 161, 1505−16. doi: 10.1016/j.chest.2022.01.021 |
[8] |
Oelberg DA, Kacmarek RM, Pappagianopoulos PP, et al. Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease. Am J Resp Crit Care, 1998; 158, 1876−82. doi: 10.1164/ajrccm.158.6.9802015 |
[9] |
Cortopassi F, Divo M, Pinto-Plata V, et al. Resting handgrip force and impaired cardiac function at rest and during exercise in COPD patients. Respir Med, 2011; 105, 748−54. doi: 10.1016/j.rmed.2010.12.011 |
[10] |
Miniati M, Catapano GA, Monti S, et al. Effects of emphysema on oxygen uptake during maximal exercise in COPD. Intern Emerg Med, 2013; 8, 41−7. |
[11] |
Parker CM, Voduc N, Aaron SD, et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J, 2005; 26, 420−8. doi: 10.1183/09031936.05.00136304 |
[12] |
Barberà JA, Roca J, Ferrer A, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J, 1997; 10, 1285−91. doi: 10.1183/09031936.97.10061285 |
[13] |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of obstructive pulmonary disease. 2022 report. https://goldcopd.org/ |
[14] |
Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J, 2005; 26, 319−38. doi: 10.1183/09031936.05.00034805 |
[15] |
American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med, 2003; 167, 211−77. doi: 10.1164/rccm.167.2.211 |
[16] |
Criner GJ, Belt P, Sternberg AL, et al. Effects of lung volume reduction surgery on gas exchange and breathing pattern during maximum exercise. Chest, 2009; 135, 1268−1279. doi: 10.1378/chest.08-1625 |
[17] |
Glaab T, Schmidt O, Fritsch J. Guidance to the interpretation of cardiopulmonary exercise testing. Pneumologie, 2020; 74, 88−102. doi: 10.1055/a-1069-0611 |
[18] |
Chiappa GR, Queiroga FJ, Meda E, et al. Heliox improves oxygen delivery and utilization during dynamic exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care, 2009; 179, 1004−10. doi: 10.1164/rccm.200811-1793OC |
[19] |
Torres-Castro R, Gimeno-Santos E, Vilaró J, et al. Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis. Eur Respir Rev, 2021; 30, 200321. doi: 10.1183/16000617.0321-2020 |
[20] |
O'Donnell DE, Elbehairy AF, Faisal A, et al. Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing. Eur Respir Rev, 2016; 25, 333−47. doi: 10.1183/16000617.0054-2016 |
[21] |
Frazão M, Silva PE, Frazão W, et al. Dynamic hyperinflation impairs cardiac performance during exercise in COPD. J Cardiopulm Rehabil Prev, 2019; 39, 187−92. doi: 10.1097/HCR.0000000000000325 |
[22] |
Come CE, Divo MJ, San José Estépar R, et al. Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial. Respir Med, 2012; 106, 109−19. doi: 10.1016/j.rmed.2011.07.012 |
[23] |
Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. New Engl J Med, 2010; 362, 217−27. doi: 10.1056/NEJMoa0808836 |
[24] |
Vassaux C, Torre-Bouscoulet L, Zeineldine S, et al. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J, 2008; 32, 1275−82. doi: 10.1183/09031936.00151707 |
[25] |
Park J, Lee CH, Lee YJ, et al. Longitudinal changes in lung hyperinflation in COPD. Int J Chron Obstruct Pulmon Dis, 2017; 12, 501−8. doi: 10.2147/COPD.S122909 |
[26] |
Silvestre OM, Nadruz W, Querejeta Roca G, et al. Declining lung function and cardiovascular risk: the ARIC study. J Am Coll Cardiol, 2018; 72, 1109−22. doi: 10.1016/j.jacc.2018.06.049 |
[27] |
Lacasse M, Maltais F, Poirier P, et al. Post-exercise heart rate recovery and mortality in chronic obstructive pulmonary disease. Respir Med, 2005; 99, 877−86. doi: 10.1016/j.rmed.2004.11.012 |
[28] |
Cole CR, Blackstone EH, Pashkow FJ, et al. Heart-rate recovery immediately after exercise as a predictor of mortality. New Engl J Med, 1999; 341, 1351−7. doi: 10.1056/NEJM199910283411804 |
[29] |
Zhang JL, Schaeffer MR, Mitchell RA, et al. A multidimensional assessment of dyspnoea in healthy adults during exercise. Eur J Appl Physiol, 2020; 120, 2533−45. doi: 10.1007/s00421-020-04479-2 |
[30] |
Souza GF, Sarmento A, Moreira GL, et al. The glittre ADL-test differentiates COPD patients with and without self-reported functional limitation. COPD J Chron Obstruct Pulmon Dis, 2020; 17, 143−149. doi: 10.1080/15412555.2020.1716707 |
[31] |
Lan CC, Chu WH, Yang MC, et al. Benefits of pulmonary rehabilitation in patients with COPD and normal exercise capacity. Respir Care, 2013; 58, 1482−8. doi: 10.4187/respcare.02051 |
[32] |
De Oca MM, Rassulo J, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care, 1996; 154, 1284−9. doi: 10.1164/ajrccm.154.5.8912737 |
[33] |
Murray SA, Kendall M, Boyd K, et al. Illness trajectories and palliative care. BMJ, 2005; 330, 1007−11. doi: 10.1136/bmj.330.7498.1007 |
[34] |
Hurst JR, Wedzicha JA. What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines. Thorax, 2007; 62, 198−9. doi: 10.1136/thx.2007.077883 |
[35] |
Hurst JR, Anzueto A, Vestbo J. Susceptibility to exacerbation in COPD. Lancet Respir Med, 2017; 5, e29. doi: 10.1016/S2213-2600(17)30307-7 |
[36] |
Gudmundsson G, Ulrik CS, Gislason T, et al. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis, 2012; 7, 571−6. |
[37] |
Wu CW, Hsieh PC, Yang MC, et al. Impact of peak oxygen pulse on patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2019; 14, 2543−2551. doi: 10.2147/COPD.S224735 |